PMGC Holdings Announces Term Sheet with Orbit2Orbit for NorthStrive Biosciences to Launch a Spaceflight Study of Its Myostatin and Activin A Assets, EL-22 and EL-32, Targeting Microgravity-Induced Mus
Go back to PMGC Holdings Announces Term Sheet with Orbit2Orbit for NorthStrive Biosciences to Launch a Spaceflight Study of Its Myostatin and Activin A Assets, EL-22 and EL-32, Targeting Microgravity-Induced Mus| (NASDAQ: ELAB) | Delayed: 4.64 -0.14 (2.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.78 | 52 Week High | $ | |||
| Open | $4.68 | 52 Week Low | $ | |||
| Day High | $4.74 | P/E | N/A | |||
| Day Low | $4.51 | EPS | $ | |||
| Volume | 9,342 | |||||
| (NASDAQ: ELAB) | Delayed: 4.64 -0.14 (2.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.78 | 52 Week High | $ | |||
| Open | $4.68 | 52 Week Low | $ | |||
| Day High | $4.74 | P/E | N/A | |||
| Day Low | $4.51 | EPS | $ | |||
| Volume | 9,342 | |||||

